Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
REN Jie, LU Bin. Innovation of diagnosis and treatment priorities and strategies under the guidance of Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition)[J]. Chinese Journal of General Practice, 2025, 23(11): 1825-1829. doi: 10.16766/j.cnki.issn.1674-4152.004237
Citation: REN Jie, LU Bin. Innovation of diagnosis and treatment priorities and strategies under the guidance of Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition)[J]. Chinese Journal of General Practice, 2025, 23(11): 1825-1829. doi: 10.16766/j.cnki.issn.1674-4152.004237

Innovation of diagnosis and treatment priorities and strategies under the guidance of Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition)

doi: 10.16766/j.cnki.issn.1674-4152.004237
Funds:

 2022XD020

 2024ZD0523206

  • Received Date: 2025-03-26
    Available Online: 2026-01-07
  • With the acceleration of population aging in China, the prevalence of diabetes continues to rise and has become a significant public health issue threatening the health of the elderly. Patients with geriatric diabetes are characterized by high heterogeneity, multiple comorbidities, high risk of complications, and great difficulty in management, which pose greater challenges to clinical diagnosis and treatment. The physiological functions and metabolic status of elderly patients with diabetes show significant differences compared with younger patients, resulting in unique features in the occurrence, progression, and treatment of the disease. Therefore, Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition) (hereinafter referred to as the "New Guidelines") have been developed. The "New Guidelines" systematically elaborate on the particularities of geriatric diabetes, diagnosis, prevention and treatment, complications, and management of comorbidities, and propose many innovative views. The "New Guidelines" emphasize the principle of individualized treatment for elderly patients with diabetes, pointing out that treatment plans should take into account factors such as the patient's age, physical condition, complications, and personal preferences to achieve the best therapeutic effect. Meanwhile, the "New Guidelines" also pay special attention to the nutritional management, exercise guidance, and mental health of elderly patients with diabetes, proposing a comprehensive integrated management strategy. This paper will review the development process and current research status of geriatric diabetes diagnosis and treatment in China in combination with the "New Guidelines", and propose the key points and improvement strategies for the diagnosis and treatment of geriatric diabetes. In addition, we will focus on the long-term follow-up and management of elderly patients with diabetes and propose how to achieve standardized comprehensive management of patients through multidisciplinary team cooperation, in order to better guide and help clinicians to achieve standardized comprehensive management of elderly patients with diabetes and improve the clinical outcomes of Chinese elderly patients with diabetes.

     

  • loading
  • [1]
    LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997. DOI: 10.1136/bmj.m997.
    [2]
    DU Q H, YANG J H, ZHANG Z C, et al. Exploring the decision-making experience of elderly diabetes patients regarding their health-seeking behaviour: a descriptive qualitative study[J]. BMJ Open, 2024, 14(10): e087126. DOI: 10.1136/bmjopen-2024-087126.
    [3]
    TANG O, MATSUSHITA K, CORESH J, et al. Mortality implications of prediabetes and diabetes in older adults[J]. Diabetes Care, 2020, 43(2): 382-388. doi: 10.2337/dc19-1221
    [4]
    DOUCET J, GOURDY P, MEYER L, et al. Management of glucose-lowering therapy in older adults with type 2 diabetes: challenges and opportunities[J]. Clin Interv Aging, 2023, 18: 1687-1703. doi: 10.2147/CIA.S423122
    [5]
    UMEGAKI H. Management of older adults with diabetes mellitus: perspective from geriatric medicine[J]. J Diabetes Investig, 2024, 15(10): 1347-1354. doi: 10.1111/jdi.14283
    [6]
    国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2024版)[J]. 中华糖尿病杂志, 2024, 16(2): 147-189.

    Center for Geriatric Medicine, Chinese Medical Association Geriatric Branch, Chinese Association of Geriatric Health Care Diabetes Committee. Chinese Geriatric Diabetes Diagnosis and Treatment Guidelines (2024 Edition)[J]. Chinese Journal of Diabetes Mellitus, 2024, 16(2): 147-189.
    [7]
    YUN J S, KIM K, AHN Y B, et al. Holistic and personalized strategies for managing in elderly type 2 diabetes patients[J]. Diabetes Metab J, 2024, 48(4): 531-545. doi: 10.4093/dmj.2024.0310
    [8]
    SALOM VENDRELL C, GARCIA TERCERO E, MORO HERNANDEZ J B, et al. Sarcopenia as a little-recognized comorbidity of type Ⅱ diabetes mellitus: a review of the diagnosis and treatment[J]. Nutrients, 2023, 15(19): 1-15.
    [9]
    BELLARY S, KYROU I, BROWN J E, et al. Type 2 diabetes mellitus in older adults: clinical considerations and management[J]. Nat Rev Endocrinol, 2021, 17(9): 534-548. doi: 10.1038/s41574-021-00512-2
    [10]
    WANG Y, LI R, YUAN L, et al. Association between diabetes complicated with comorbidities and frailty in older adults: a cross-sectional study[J]. J Clin Nurs, 2023, 32(5-6): 894-900. doi: 10.1111/jocn.16442
    [11]
    NISHIMURA A, MASUDA C, MURAUCHI C, et al. Relationship between frailty and diabetic pharmacologic therapy in older adults with type 2 diabetes: a cross-sectional study[J]. Drugs Aging, 2024, 41(6): 531-542. doi: 10.1007/s40266-024-01119-8
    [12]
    RASHIDI M, YILDIRIM G, KARAMAN F, et al. Determination of the relationship between frailty level and quality of life in elderly individuals with type 2 diabetes[J]. Sci Rep, 2024, 14(1): 32028. DOI: 10.1038/s41598-024-83766-w.
    [13]
    DENG L F, LUO S T, WANG T Y, et al. Depression screening model for middle-aged and elderly diabetic patients in China[J]. Sci Rep, 2024, 14(1): 29158. DOI: 10.1038/s41598-024-80816-1.
    [14]
    CHEN L K, CHEN Y M, LIN M H, et al. Care of elderly patients with diabetes mellitus: a focus on frailty[J]. Ageing Res Rev, 2010, 9 Suppl 1: S18-S22.
    [15]
    BILAL A, PRATLEY R E. Newer glucose-lowering therapies in older adults with type 2 diabetes[J]. Endocrinol Metab Clin North Am, 2023, 52(2): 355-375. doi: 10.1016/j.ecl.2022.10.010
    [16]
    American Diabetes Association Professional Practice Committee. 13. older adults: standards of care in diabetes-2025[J]. Diabetes Care, 2025, 48(1 Suppl 1): S266-S282.
    [17]
    PRATLEY R E, KANAPKA L G, RICKELS M R, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial[J]. JAMA, 2020, 323(23): 2397-2406. doi: 10.1001/jama.2020.6928
    [18]
    倪青, 卜祥伟. 老年糖尿病中医诊疗指南[J]. 中华全科医学, 2024, 22(8): 1272-1278.

    NI Q, BU X W. Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Geriatric Diabetes[J]. Chinese Journal of General Practice, 2024, 22(8): 1272-1278.
    [19]
    KIM K, KIM B, LEE K, et al. Older adults with diabetes in Korea: latest clinical and epidemiologic trends[J]. Diabetes Metab J, 2025, 49(2): 183-193. doi: 10.4093/dmj.2024.0836
    [20]
    WANG W X, KONG L N, ZENG L, et al. Exercise interventions for frail older adults with diabetes: a scoping review[J]. Geriatr Nurs, 2024, 58: 200-207. doi: 10.1016/j.gerinurse.2024.05.030
    [21]
    LIU Y, WANG X X, REN X W, et al. Association of physical activity and dietary diversity with cognitive function in the elderly with type 2 diabetes mellitus: findings from a cross-sectional study[J]. J Am Nutr Assoc, 2025, 44(2): 104-114.
    [22]
    RICHARDSON K M, SCHEMBRE S M, DA SILVA V, et al. Adding a brief continuous glucose monitoring intervention to the National Diabetes Prevention Program: a multimethod feasibility study[J]. J Diabetes Res, 2024, 2024: 7687694. DOI: 10.1155/2024/7687694.
    [23]
    FLOREZ J C. Advancing precision medicine in type 2 diabetes[J]. Lancet Diabetes Endocrinol, 2024, 12(2): 87-88. doi: 10.1016/S2213-8587(23)00384-4
    [24]
    中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2): 120-139.

    Chinese Medical Doctor Association Endocrinology and Metabolism Branch, National Clinical Research Center for Metabolic Diseases (Changsha). Chinese Expert Consensus on the classification and diagnosis of diabetes[J]. Chinese Journal of Diabetes Mellitus, 2022, 14(2): 120-139.
    [25]
    SOKOLOWSKI E K, KURSAWE R, SELVAM V, et al. Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights[J]. Cell Metab, 2024, 36(11): 2468-2488. doi: 10.1016/j.cmet.2024.09.006
    [26]
    JIA W P, CHAN J C, WONG T Y, et al. Diabetes in China: epidemiology, pathophysiology and multi-omics[J]. Nat Metab, 2025, 7(1): 16-34. doi: 10.1038/s42255-024-01190-w
    [27]
    CHAN J C N, LIM L L, WAREHAM N J, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives[J]. Lancet, 2021, 396(10267): 2019-2082.
    [28]
    TOBIAS D K, MERINO J, AHMAD A, et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine[J]. Nat Med, 2023, 29(10): 2438-2457. doi: 10.1038/s41591-023-02502-5
    [29]
    CARRASCO-ZANINI J, PIETZNER M, WHEELER E, et al. Multi-omic prediction of incident type 2 diabetes[J]. Diabetologia, 2024, 67(1): 102-112. doi: 10.1007/s00125-023-06027-x
    [30]
    朱文奎, 刘炜, 徐群, 等. MemTrax在线工具在社区老年糖尿病认知功能筛查中的应用价值[J]. 中华全科医学, 2023, 21(12): 2089-2092.

    ZHU W K, LIU W, XU Q, et al. Application value of the MemTrax Online Tool in cognitive function screening of elderly patients with diabetes in the community[J]. Chinese Journal of General Practice, 2023, 21(12): 2089-2092.
    [31]
    RAVAUT M, HARISH V, SADEGHI H, et al. Development and validation of a machine learning model using administrative health data to predict onset of type 2 diabetes[J]. JAMA Netw Open, 2021, 4(5): e2111315. DOI: 10.1001/jamanetworkopen.2021.11315.
    [32]
    SCHÖN M, PRYSTUPA K, MORI T, et al. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort[J]. Lancet Diabetes Endocrinol, 2024, 12(2): 119-131. doi: 10.1016/S2213-8587(23)00329-7
    [33]
    NOMURA A, NOGUCHI M, KOMETANI M, et al. Artificial Intelligence in current diabetes management and prediction[J]. Curr Diab Rep, 2021, 21(12): 61. DOI: 10.1007/s11892-021-01423-2.
    [34]
    RAJESH A E, DAVIDSON O Q, LEE C S, et al. Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness[J]. Diabetes Care, 2023, 46(10): 1728-1739. doi: 10.2337/dci23-0032
    [35]
    GUAN Z Y, LI H T, LIU R H, et al. Artificial intelligence in diabetes management: advancements, opportunities, and challenges[J]. Cell Rep Med, 2023, 4(10): 101213. DOI: 10.1016/j.xcrm.2023.101213.
    [36]
    SOWAH R A, BAMPOE-ADDO A A, ARMOO S K, et al. Design and development of diabetes management system using machine learning[J]. Int J Telemed Appl, 2020, 2020: 8870141. DOI: 10.1155/2020/8870141.
    [37]
    AMERZADEH M, KISOMI Z S, SENMAR M, et al. Author Correction: self-care behaviors, medication adherence status, and associated factors among elderly individuals with type 2 diabetes[J]. Sci Rep, 2024, 14(1): 23039. DOI: 10.1038/s41598-024-74248-0.
    [38]
    ZAN H J, MENG Z X, LI J, et al. Factors associated with quality of life among elderly patients with type 2 diabetes mellitus: the role of family caregivers[J]. BMC Public Health, 2024, 24(1): 539. DOI: 10.1186/s12889-024-17917-z.
    [39]
    王俊薇, 刘云, 李连喜. 中国糖尿病管理模式及思考[J]. 中国全科医学, 2021, 24(24): 3019-3025.

    WANG J W, LIU Y, LI L X. Management modes and considerations of diabetes in China[J]. Chinese General Practice, 2021, 24(24): 3019-3025.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (110) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return